Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2022
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives
Federica Barbieri, Alessia Graziana Bosio, Alessandra Pattarozzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin
Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 19, 2023
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
Adriana Amaro, Francesco Reggiani, Daniela Fenoglio, et al.
Molecular Therapy. Nucleic Acids
|
December 30, 2025
Synergic microRNAs suppress human glioblastoma progression by modulating clinically relevant targets
Silvia Rancati, Rui C Pereira, Michele Schlich, et al.
Cell Cycle (Georgetown, Tex.)
|
October 10, 2008
A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity
Raffaella Ponassi, Barbara Biasotti, Valeria Tomati, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
Journal of Experimental & Clinical Cancer Research : CR
|
February 9, 2022
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives
Federica Barbieri, Alessia Graziana Bosio, Alessandra Pattarozzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin
Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 19, 2023
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
Adriana Amaro, Francesco Reggiani, Daniela Fenoglio, et al.
Molecular Therapy. Nucleic Acids
|
December 30, 2025
Synergic microRNAs suppress human glioblastoma progression by modulating clinically relevant targets
Silvia Rancati, Rui C Pereira, Michele Schlich, et al.
Cell Cycle (Georgetown, Tex.)
|
October 10, 2008
A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity
Raffaella Ponassi, Barbara Biasotti, Valeria Tomati, et al.
Page
of 8